stars 1 stars 2 stars 3

Innobiochips develops the SirYus technology, a disruptive way to design, manufacture and read multiplex immunoassays, paving the way for innovative diagnostics solutions for human health. Fast, reliable, powerful: SirYus technology takes in vitro diagnostics to the next level and opens new possibilities : #transplantation - #transfusion - #InfectiousDiseases - #microbiome

Innobiochips Questions

The Innobiochips annual revenue was $4 million in 2026.

Vianney Souplet is the CEO of Innobiochips.

18 people are employed at Innobiochips.

Innobiochips is based in Loos, Hauts-de-France.

The NAICS codes for Innobiochips are [32, 32541, 325413, 325, 3254].

The SIC codes for Innobiochips are [283, 28].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users